Temporal Release of Cell Cycle Regulator α-Lipoic Acid: An NIR-Light (Two-Photon) Activatable Quinoxaline-Based Nano-Prodrug Delivery System

ACS Appl Mater Interfaces. 2023 Jul 12;15(27):32099-32109. doi: 10.1021/acsami.3c02744. Epub 2023 Jun 29.

Abstract

The regulation of the cell cycle has recently opened up a new research perspective for cancer treatment. So far, no effort has been made for temporal control of cell cycles using a photocleavable linker. Presented herein is the first report of regulation of disrupted cell cycles through the temporal release of a well-known cell cycle regulator α-lipoic acid (ALA), enabled by a newly designed NIR-active quinoxaline-based photoremovable protecting group (PRPG). The suitable quinoxaline-based photocage of ALA (tetraphenylethelene conjugated) has been formulated as fluorescent organic nanoparticles (FONs) and used effectively as a nano-DDS (drug delivery system) for better solubility and cellular internalization. Fascinatingly, the enhanced TP (two-photon) absorption cross section of the nano-DDS (503 GM) signifies its utility for biological applications. Using green light, we have successfully controlled the time span of cell cycles and cell growth of skin melanoma cell lines (B16F10) by the temporal release of ALA. Further, in silico studies and PDH activity assay supported the observed regulatory behavior of our nano-DDS with respect to photoirradiation. Overall, this approach expands the research path toward a futuristic photocontrolled toolbox for cell cycle regulation.

Keywords: NIR-active photoremovable protecting groups; cancer treatment; cell cycle regulation; quinoxaline-based nano-DDS; two-photon active organic nanoparticles.

MeSH terms

  • Cell Cycle
  • Drug Delivery Systems / methods
  • Nanoparticle Drug Delivery System
  • Nanoparticles*
  • Prodrugs*
  • Quinoxalines / pharmacology
  • Thioctic Acid*

Substances

  • Prodrugs
  • Thioctic Acid
  • Nanoparticle Drug Delivery System
  • Quinoxalines